Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metabolism-Associated Gene Signatures for FDG Avidity on PET/CT and Prognostic Validation in Hepatocellular Carcinoma

31 Jan 2022

Abstract excerpt

Introduction The prognostic value of F-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in hepatocellular carcinoma (HCC) was established in previous reports. However, there is no evidence suggesting the prognostic value of transcriptomes associated with tumor FDG uptake in HCC. It was aimed to elucidate metabolic genes and functions associated with FDG uptake, followed by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Hypoxia, and Metabolism
Share to Cancer, Lipids, and Metabolism
Share to Hepatocellular Carcinoma Treatment and Prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35174098
DOI: 10.3389/fonc.2022.845900

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metabolism-Associated Gene Signatures for FDG Avidity on PET/CT and Prognostic Validation in Hepatocellular CarcinomaPMID 35174098Read ↗

Identification and Validation of a Novel Metabolism‑Related Prognostic Signature in Hepatocellular CarcinomaSemantic proximity Read ↗

A Nomogram Based on Glycolysis-related Gene Expression Profilings Serve as a Novel Prognosis Risk Classifiers for Human Hepatocellular CarcinomaSemantic proximity Read ↗

Glycolysis-related gene expression profiling serves as a novel prognosis risk predictor for human hepatocellular carcinomaSemantic proximity Read ↗

Metabolism‐associated molecular classification of hepatocellular carcinomaSemantic proximity Read ↗

A novel prognostic model for hepatocellular carcinoma based on pyruvate metabolism-related genesSemantic proximity Read ↗

Prognostic Implication of a Novel Metabolism-Related Gene Signature in Hepatocellular CarcinomaSemantic proximity Read ↗

Construction and Validation of a Metabolic Reprogramming Related Prognostic Model for Hepatocellular CarcinomaSemantic proximity Read ↗

Identification of a novel metabolism‑related prognostic signature in hepatocellular carcinoma through bioinformatics analysis and validation through experimental studiesSemantic proximity Read ↗

A novel prognostic signature based on four glycolysis‐related genes predicts survival and clinical risk of hepatocellular carcinomaSemantic proximity Read ↗

Fatty Acid Metabolism-Related Genes Are Potential Biomarkers for Prognostic Prediction and Clinical Guidance in Patients with Hepatocellular CarcinomaSemantic proximity Read ↗

Identification of Prognostic Genes Associated with Expression Differentiation During Metabolism Process in Hepatocellular Carcinoma (HCC)Semantic proximity Read ↗

A Novel Nomogram Based on Lipid Metabolism-related Risk Gene Expression Can Better Predict Overall Survival for Hepatocellular CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.